SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001165527-16-000940
Filing Date
2016-11-18
Accepted
2016-11-18 10:33:27
Documents
49
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 g8331a.htm 10-Q 694258
2 ex3-1.htm EX-3.1 73394
3 ex31-1.htm EX-31.1 15009
4 ex31-2.htm EX-31.2 15049
5 ex32.htm EX-32 7026
  Complete submission text file 0001165527-16-000940.txt   3197090

Data Files

Seq Description Document Type Size
6 clcs-20160930.xml EX-101.INS 601088
7 clcs-20160930.xsd EX-101.SCH 27648
8 clcs-20160930_cal.xml EX-101.CAL 29023
9 clcs-20160930_def.xml EX-101.DEF 90416
10 clcs-20160930_lab.xml EX-101.LAB 252805
11 clcs-20160930_pre.xml EX-101.PRE 174418
Mailing Address 65 YIGAL ALON STREET TEL AVIV L3 67433
Business Address 65 YIGAL ALON STREET TEL AVIV L3 67433 011 972 3 562-1755
Cell Source, Inc. (Filer) CIK: 0001569340 (see all company filings)

IRS No.: 320379665 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55413 | Film No.: 162006710
SIC: 2834 Pharmaceutical Preparations